Coloplast A/S
CLPBYOTCHealthcare● Active
$5.94
$-0.02(-0.34%)
Market Cap$13.4B
P/E Ratio—
52W High$10.03
52W Low$5.88
Coloplast A/S（CLPBY）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · CLPBY · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-09 | 2024-09 | 2023-09 | 2022-09 | 2021-09 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $3.42B | $5.05B | $6.77B | $6.44B | $6.16B |
| Depreciation & Amort. | $1.27B | $1.29B | $1.07B | $0.93B | $0.79B |
| Stock-Based Comp. | $0.00B | $0.00B | $0.06B | $0.05B | $0.05B |
| Change in Working Capital | ($0.74B) | ($1.03B) | ($0.89B) | ($0.85B) | ($0.07B) |
| Net Cash from Operations | $6.26B | $2.77B | $4.23B | $5.10B | $5.29B |
| Investing Activities | |||||
| Capital Expenditure | ($1.23B) | ($1.17B) | ($1.24B) | ($1.14B) | ($1.97B) |
| Purchases of Investments | ($0.02B) | ($0.01B) | ($0.02B) | ($0.00B) | ($0.01B) |
| Sales of Investments | $0.00B | $0.00B | $0.22B | $0.00B | $0.03B |
| Net Cash from Investing | ($1.18B) | ($1.34B) | ($8.96B) | ($11.76B) | ($2.01B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | ($0.62B) | ($0.50B) |
| Dividends Paid | ($4.67B) | ($4.72B) | ($4.25B) | ($4.04B) | ($3.83B) |
| Debt Issued / Repaid | $0.02B | $2.97B | $0.62B | $10.97B | ($0.20B) |
| Net Cash from Financing | ($4.89B) | ($1.52B) | $5.26B | $6.59B | ($3.18B) |
| Free Cash Flow | |||||
| Free Cash Flow | $5.03B | $1.60B | $2.98B | $3.96B | $3.32B |
| FCF Margin %(computed) | 19.16% | 5.92% | 12.18% | 17.56% | 17.11% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · DKK · B
深入了解Coloplast A/S
关于Coloplast A/S（CLPBY）现金流量表
Coloplast A/S 2025财年经营活动现金流$6.26B，自由现金流$5.03B（FCF利润率19.16%），资本支出($1.23B)。
常见问题
CLPBY · 4 问Coloplast A/S 2025财年自由现金流$5.03B，同比up214.3%。
CLPBY free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10